Previous close | 11.19 |
Open | 8.03 |
Bid | 14.30 |
Ask | 22.10 |
Strike | 430.00 |
Expiry date | 2024-06-28 |
Day's range | 8.03 - 11.19 |
Contract range | N/A |
Volume | |
Open interest | 11 |
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
(Bloomberg) -- S&P Global Inc. named Martina Cheung, the president of its credit ratings division, as its next chief executive officer. Most Read from BloombergSupreme Court Poised to Allow Emergency Abortions in IdahoSpaceX Tender Offer Said to Value Company at Record $210 BillionSupreme Court Ends OxyContin Settlement, Cracking Sackler ShieldChina’s Finance Elite Face $400,000 Pay Cap, Bonus ClawbacksBolivia’s President Arce Swears in New Army Chief After Coup BidCheung will become CEO effecti
Cheung, who has held multiple leadership roles at S&P Global in her 14-year stint, will succeed Douglas Peterson, the company's chief executive since 2013. S&P Global announced that retiring CEO Peterson will remain with the board until May 2025, and will be a special adviser to the company till Dec. 31, 2025. This trend bodes well for companies such as S&P Global, known for its rating agency business and stock market indexes.